Table 1.
Selected relevant genes with significant (P < 0.005) differential gene expression in equine BMDMSCs treated with AdBMP12, compared with cells treated with AdGFP.
Equine Genbank accession No. | Sequence name | Biological function | Factor of change | P value |
---|---|---|---|---|
CD466560 | Myristoylated alanine-rich protein kinase C substrate | Calmodulin binding, actin filament binding | 1.85 | < 0.001 |
CD528599 | Transcription elongation factor A | Regulation of transcription | 0.62 | < 0.001 |
BI961271 | Ferritin, light polypeptide storage protein | Intracellular iron | 0.61 | < 0.001 |
CD465526 | Glutamine synthase, mRNA | Metabolism of nitrogen | 0.61 | < 0.001 |
CD467815 | Ganglioside activator protein | Innate immunity, lipid metabolism | 0.75 | 0.002 |
BM780348 | Ubiquinol-cytochrome c reductase core protein l | Mitochondrial respiratory chain | 1.26 | 0.002 |
BI961520 | Peroxiredoxin 1 | Antioxidant enzyme | 0.75 | 0.002 |
BI961470 | Chondroitin sulfate proteoglycan 2 (versican) | Extracellular matrix proteoglycan | 4.35 | 0.002 |
CD466435 | DEAD/H Box (Asp-Glu-Ala-Asp/His) | Positive regulation cell proliferation | 2.08 | 0.002 |
BM781267 | Laminin receptor 1 | Mediate effects of laminin, extracellular matrix protein, cell adhesion molecule | 0.79 | 0.002 |
BM780407 | Heat shock 90-kd protein 1, Alpha-like 3 | Stress proteins | 0.58 | 0.004 |